left space About Us Product Candidates Newsroom Investor Information Business Development

IDDS logo

  Javelin is a specialty pharmaceutical company committed to the development of drugs to treat intense, moderate-to-severe pain
Read more
pixel shim

pixel shim
 AMEX :: JAV
pixel shim pixel shim
Quote 1.39
Change -0.06
Date 11/27/2009
Time 1:01pm
Min Delayed Quote
pixel shim

 

2008 Annual Report & Proxy

Click here to download
Javelin's Annual Report for 2008

 

Javelin Pharma's Chinese Microsite

 

News:

November 10, 2009
Javelin Pharmaceuticals, Inc. Reports Third Quarter 2009 Results

November 4, 2009
Javelin to Announce Third Quarter Results
Click here for the webcast
(Registration Required)

September 30, 2009
Javelin Pharmaceuticals, Inc. Tops Up Balance Sheet Through Registered Direct Offering

August 11, 2009
Javelin Pharmaceuticals Reports Ereska (Intranasal Ketamine) Phase III Trial Results in Postoperative Orthopedic Pain

August 11, 2009
Javelin Pharmaceuticals, Inc. Reports Second Quarter 2009 Results and Corporate Highlights

June 23, 2009
Javelin Pharmaceuticals Completes Open Label Safety Study of Dyloject™



 



  
 

 

CONTACT US   JOIN US   SITE MAP
© 2005-2009 Javelin Pharmaceuticals,Inc. / Intrac,Inc. /IDDS,Inc. All rights reserved. All other trademarks are the properties of their respective owners. Reproduction in whole or in part in any form or medium without express written permission of Javelin Pharmaceuticals,Inc. / Intrac,Inc. /IDDS,Inc. is prohibited.